Co-Diagnostics, Inc. Announces Participation in Research Project with Stanford University
CoPrimers™ used in proof of concept evaluation SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, ...
Home » molecular diagnostics
CoPrimers™ used in proof of concept evaluation SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, ...
CODX updates on initial six months as a public company SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics ...
Project moving forward on schedule, with production to begin in Q3 2018 SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a ...
Audit to prepare for eventual sales into the US market SALT LAKE CITY--CODX, (BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or ...
Technology shown to distinguish disease-causing potentially life-threatening Staphylococcus strains from Staphylococcus present due to environmental contamination, supporting more accurate diagnosis, ...